The student will be able to understand the current challenges of the health care system in terms of managing therapeutic innovation and to outline and critically interpret cost-effectiveness analyses of medicines.
The objectives of the course are: -understand the context and rationale of pharmacoeconomics (the "why") -acquire the key analytical concepts used in pharmacoeconomics (the "how")
The course presents both the context and the methodological outlines of pharmaco-economics
Written examination.
The course slides as well as the methodological recommendations of the KCE (Belgium) and the HAS (France) are provided to the students.
| Training | Study programme | Block | Credits | Mandatory |
|---|---|---|---|---|
| Master 120 en sciences pharmaceutiques, à finalité spécialisée | Standard | 0 | 2 | |
| Master 120 en sciences pharmaceutiques, à finalité spécialisée | Standard | 1 | 2 |